Loading…
Geranylgeranylacetone Protects Membranes against Nonsteroidal Anti-Inflammatory Drugs
Direct gastric mucosal cell damage mediated by nonsteroidal anti-inflammatory drugs (NSAIDs) is involved in the formation of NSAID-induced gastric lesions. We recently suggested that this direct cytotoxicity of NSAIDs is caused by their membrane-permeabilization activity. Geranylgeranylacetone (GGA)...
Saved in:
Published in: | Molecular pharmacology 2005-10, Vol.68 (4), p.1156-1161 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Direct gastric mucosal cell damage mediated by nonsteroidal anti-inflammatory drugs (NSAIDs) is involved in the formation
of NSAID-induced gastric lesions. We recently suggested that this direct cytotoxicity of NSAIDs is caused by their membrane-permeabilization
activity. Geranylgeranylacetone (GGA), a clinically used antiulcer drug, can protect gastric mucosa against lesion formation
mediated by NSAIDs. However, the mechanism by which this occurs is not fully understood. In this study, we show that GGA acts
to stabilize membranes against NSAIDs. GGA suppressed NSAID-induced permeabilization of calcein-loaded liposomes and NSAID-induced
stimulation of K + -efflux across the cytoplasmic membrane in cells. GGA was effective even when coadministered with NSAIDs and was also able
to restore membrane fluidity that had been compromised by NSAIDs. This mechanism seems to play an important role in the antiulcer
activity of GGA. |
---|---|
ISSN: | 0026-895X 1521-0111 |
DOI: | 10.1124/mol.105.015784 |